BC Week In Review | Jan 4, 2019
Financial News

Rakuten Aspyrian grows series C to $284M

Rakuten Aspyrian Inc. (San Diego, Calif.) raised $134 million led by CEO Hiroshi Mikitani in the second tranche of a $284 million series C round as the company conducts a Phase III trial of photoimmunotherapy...
BC Extra | Dec 22, 2018
Financial News

Rakuten Aspyrian grows series C to $284M

Rakuten Aspyrian Inc. (San Diego, Calif.) raised $134 million led by CEO Hiroshi Mikitani in the second tranche of a $284 million series C round as the company conducts a Phase III trial of photoimmunotherapy...
BC Week In Review | Aug 31, 2018
Financial News

Rakuten’s Mikitani leads Aspyrian's $150M series C

Rakuten Aspyrian Inc. (San Diego, Calif.) raised $150 million on Aug. 23 in a series C round led by Chairman Hiroshi Mikitani, who is CEO of Japanese e-commerce company Rakuten Inc. (Tokyo:4755). The round included...
BC Extra | Aug 23, 2018
Financial News

Rakuten’s Mikitani leads Aspyrian's $150M series C

Rakuten Aspyrian Inc. (San Diego, Calif.) raised $150 million in a series C round led by Chairman Hiroshi Mikitani, who is CEO of Japanese e-commerce company Rakuten Inc. (Tokyo:4755). The round included other undisclosed private...
BC Innovations | Oct 13, 2016
Translation in Brief

Zapping Tregs

A team at NIH's National Cancer Institute (NCI) has developed a phototherapy that selectively ablates Tregs in tumors to avoid the autoimmune liabilities of systemic immunotherapies. Despite their impressive efficacy, checkpoint inhibitors marketed to treat...
BC Innovations | Sep 1, 2016
Distillery Therapeutics

Therapeutics: Interleukin-2 receptor α chain (CD25)

Cancer INDICATION: Cancer Mouse studies suggest a conjugate of an anti- CD25 mAb and a near-infrared (NIR) light-sensitive dye could help treat cancer. In cultures of a CD25-expressing mouse T cell line exposed to NIR,...
BC Extra | Mar 11, 2016
Financial News

Aspyrian raises $40M in series B round

Aspyrian Therapeutics Inc. (San Diego, Calif.) raised $40 million in a series B round from Hiroshi Mikitani, an Aspyrian director. Mikitani is CEO of Japanese e-commerce company Rakuten Inc. (Tokyo:4755). Aspyrian has an exclusive license...
Items per page:
1 - 7 of 7